A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile-Reference-Cited by-同舟云学术

A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile

Published:2023-03 Issue:3 Volume:4 Page:100955
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Sannier Gérémy,Nicolas Alexandre,Dubé Mathieu,Marchitto Lorie,Nayrac Manon,Tastet Olivier,Chatterjee Debashree,Tauzin Alexandra,Lima-Barbosa Raphaël,Laporte Mélanie,Cloutier Rose,Sreng Flores Alina M.,Boutin Marianne,Gong Shang Yu,Benlarbi Mehdi,Ding Shilei,Bourassa Catherine,Gendron-Lepage Gabrielle,Medjahed Halima,Goyette Guillaume,Brassard Nathalie,Delgado Gloria-Gabrielle,Niessl Julia,Gokool Laurie,Morrisseau Chantal,Arlotto Pascale,Rios Norka,Tremblay Cécile,Martel-Laferrière Valérie,Prat Alexandre,Bélair Justin,Beaubien-Souligny William,Goupil Rémi,Nadeau-Fredette Annie-Claire,Lamarche Caroline,Finzi Andrés,Suri Rita S.,Kaufmann Daniel E.^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference72 articles.

1. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data;Haas;Lancet,2021

2. Association between mRNA vaccination and COVID-19 hospitalization and disease severity;Tenforde;JAMA,2021

3. Evidence for antibody as a protective correlate for COVID-19 vaccines;Earle;Vaccine,2021

4. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial;Gilbert;Science,2022

5. Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses;Tauzin;Cell Host Microbe,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term levels of protection of different types of immunity against the Omicron variant: a rapid literature review;Swiss Medical Weekly;2024-05-06

2. Enhanced detection of antigen-specific T cells by a multiplexed AIM assay;Cell Reports Methods;2024-01

3. Longitudinal Immunogenicity Study of SARS-CoV-2 mRNA Vaccines Across Subjects with Different Immunocompromising Conditions: Heterogeneity in the Immune Response and Crucial Role of the Booster Dose;2024

4. Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV;Viruses;2023-09-26